References
Hilliard CB (2016) High osteoporosis risk among East Africans linked to lactase persistence genotype. BoneKEy Rep. doi:10.1038/bonekey.2016.30
Fu S, Hirte H, Welch S et al (2017) First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors. Invest New Drugs 35:324
Jiang Y, Gou H, Zhu J, Tian S, Yu L (2016) Lidocaine inhibits the invasion and migration of TRPV6-expressing cancer cells by TRPV6 downregulation. Oncol Lett 12(2):1164–1170
Funding
I, Constance Hilliard, certify that I have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials presented in this letter-to-the-editor.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hilliard, C. Letter to the editor: In response to “influence of clinical, societal, and treatment variables on racial difference in ER-/PR- breast cancer survival” by Roseland ME, Schwartz K, Ruterbusch JJ, Lamerato L, Krajenta R, Booza J, Simon MS. Breast Cancer Res Treat 166, 321–322 (2017). https://doi.org/10.1007/s10549-017-4360-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-017-4360-z